Vigilant Capital Management, LLC - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,090 filers reported holding BAXTER INTL INC in Q2 2021. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Vigilant Capital Management, LLC ownership history of BAXTER INTL INC
ValueSharesWeighting
Q4 2022$50
-99.9%
9800.0%0.00%
-20.0%
Q3 2022$53,000
-15.9%
9800.0%0.01%0.0%
Q2 2022$63,000
-17.1%
9800.0%0.01%
-16.7%
Q1 2022$76,000
-9.5%
9800.0%0.01%0.0%
Q4 2021$84,000
-48.1%
980
-51.5%
0.01%
-53.8%
Q3 2021$162,000
-0.6%
2,0200.0%0.01%0.0%
Q2 2021$163,000
+8.7%
2,020
+13.5%
0.01%0.0%
Q1 2021$150,000
+4.9%
1,7800.0%0.01%
-7.1%
Q4 2020$143,0000.0%1,7800.0%0.01%
-12.5%
Q3 2020$143,000
-6.5%
1,7800.0%0.02%
-15.8%
Q2 2020$153,000
-5.0%
1,780
-10.1%
0.02%
-17.4%
Q1 2020$161,000
-3.0%
1,9800.0%0.02%
+21.1%
Q4 2019$166,000
+6.4%
1,980
+11.2%
0.02%
-5.0%
Q3 2019$156,000
+6.8%
1,7800.0%0.02%0.0%
Q2 2019$146,000
+0.7%
1,7800.0%0.02%0.0%
Q1 2019$145,000
+23.9%
1,7800.0%0.02%
+5.3%
Q4 2018$117,000
-14.6%
1,7800.0%0.02%
+5.6%
Q3 2018$137,000
+4.6%
1,7800.0%0.02%
-5.3%
Q2 2018$131,000
+6450.0%
1,780
+7990.9%
0.02%
Q1 2014$2,000220.00%
Other shareholders
BAXTER INTL INC shareholders Q2 2021
NameSharesValueWeighting ↓
Third Point 41,000,000$2,482,140,00022.00%
THUNDERBIRD PARTNERS LLP 1,711,643$103,623,00012.17%
SECTOR GAMMA AS 1,070,333$64,798,0009.42%
Veritas Asset Management LLP 10,179,102$616,243,0004.81%
13D Management LLC 194,807$11,794,0004.18%
Progressive Investment Management Corp 78,316$4,741,0003.69%
Aristotle Capital Management, LLC 6,846,307$414,476,0003.46%
ARGENT CAPITAL MANAGEMENT LLC 1,394,075$84,397,0003.37%
Lipe & Dalton 80,073$4,848,0003.14%
PURA VIDA INVESTMENTS, LLC 125,000$7,568,0003.00%
View complete list of BAXTER INTL INC shareholders